Annals of Surgical Oncology

, Volume 15, Issue 12, pp 3327–3330 | Cite as

Comprehensive Management of Disseminated Colorectal Cancer

Gastrointestinal Oncology

References

  1. 1.
    Foster JH, Berman MM. Solid liver tumors. Major Probl Clin Surg. 1977;22:1–342.PubMedGoogle Scholar
  2. 2.
    Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg. 1984;119:647–51.PubMedGoogle Scholar
  3. 3.
    Hughes KS, Simon RM, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery. 1987;103:278–88.Google Scholar
  4. 4.
    Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum. 1988;31:1–4.Google Scholar
  5. 5.
    Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery. 1995;117:296–304.PubMedCrossRefGoogle Scholar
  6. 6.
    Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am. 1989;69:339–59.PubMedGoogle Scholar
  7. 7.
    Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Elias D, Dube P, Bonvalot S, et al. Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: feasibility and preliminary results. Hepatogastroenterology. 1999;46:360–3.PubMedGoogle Scholar
  9. 9.
    Carmignani CP, Ortega-Perez G, Sugarbaker PH. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol. 2004;30:391–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8:347–53.PubMedCrossRefGoogle Scholar
  11. 11.
    Kaido T. Verification of evidence in surgical treatment for colorectal liver metastasis. Hepatogastroenterology. 2008;55:378–80.PubMedGoogle Scholar
  12. 12.
    Sugarbaker P. Peritonectomy procedures. Ann Surg. 1995;221:29–42.PubMedGoogle Scholar
  13. 13.
    Spratt JS, Adcock RA, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40:256–60.PubMedGoogle Scholar
  14. 14.
    Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61:232–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Sugarbaker PH, Graves T, DeBruijn EA, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res. 1990;50:5790–4.PubMedGoogle Scholar
  16. 16.
    Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221:124–32.PubMedCrossRefGoogle Scholar
  17. 17.
    Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Gertsch P. A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg Oncol Clin N Am. 2003;12:531–41.PubMedCrossRefGoogle Scholar
  20. 20.
    Sugarbaker PH. Carcinomatosis—is cure an option? (editorial). J Clin Oncol. 2003;21:762–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Shen P, Thai K, Stewart JH, et al. Peritoneal surface disease from colorectal cancer: Comparison to the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol. (in press).Google Scholar
  22. 22.
    Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol. 1999;43(Suppl):S15–25PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2008

Authors and Affiliations

  1. 1.Washington Cancer Institute, Washington Hospital CenterWashingtonUSA

Personalised recommendations